NLRP3 and mood disorder: In this context, this narrative review presents an overview of preclinical and clinical studies that support a role of the NLRP3 inflammasome in the pathogenesis of MDD, highlighting that pathways related to NLRP3 inflammasome represent promising strategies for the treatment of this mood disorder.